semaglutide fda approval mash Approves Wegovy for Liver Disease Treatment | Jennifer D Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP posted on the topic Semaglutide FDA Approved MASH Treatment

Its side-effect column describes variable results including loss of efficacy and rebound appetite, and its guidance column says to contact your provider immediately if that happens

Method The study was a two-group, randomized controlled trial

Semaglutide or Tirzepatide for Type 2 Diabetes Both of the medications are highly used to manage type 2 diabetes

In August 2025 , Wegovy became the first GLP-1 therapy approved to treat non-cirrhotic MASH (liver disease)

Prescription medication cannot be cancelled after dispatch

Stop using Semaglutide and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting